FDA device listing
LIAISON XL MUREX Anti-HBe,LIAISON XL MUREX Control Anti-HBe
FDA device listing 1951286005 · DiaSorin Inc.
Key facts
| Proprietary names | LIAISON XL MUREX Anti-HBe,LIAISON XL MUREX Control Anti-HBe |
|---|---|
| Owner/operator | DiaSorin Inc. |
| Owner/operator number | 9051149 |
| Premarket submissions | P180049 |
| Product codes | LOM, SEI |
| Device names | LOM - Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen), SEI - Qualitative And Quantitative Hepatitis B Virus Antibody Assays |
| Device class | Class II |
| Classification regulations (21 CFR) | 866.3172, 866.3173 |
| Review panels | Microbiology |
| Registered establishments | DiaSorin Italia S.p.A. |
| Establishment registrations | 9610240 |
| FEI numbers | 3002808212 |
| Establishment operations | Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- 1–9 UDI devices (GUDID) under the same submission
- 1–9 Device listings citing the same submission
- Yes Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database